April 29th 2024
The CDMO’s boost in production will be centered around pharmaceutical products.
Ten23 Expands Sterile Manufacturing Capacity at VIVA 1 Facility
September 13th 2023Further expansions of the pharmaceutical development and manufacturing services of ten23 are happening at the BASE and VIVA facilities to continue to support complex sterile product development, testing, and manufacturing.